Revenue (Annual)

Revenue: The sum of all revenue fields included for a company's operating activities.

Starpharma Holdings Ltd. (SPHRY) had Revenue of $3.79M for the most recently reported fiscal year, ending 2025-06-30.

Quarterly Annual

Figures for fiscal year ending 2025-06-30

Income Statement Financials
Revenue	$3.79M
Net Income	$-6.47M
Cost of Goods Sold	$0.79M
Gross Profit	$3.00M
Operating Expenses	$10.26M
Operating Income	$-6.47M
Non-Operating Income/Expense	--
Pre-Tax Income	$-6.47M
Normalized Pre-Tax Income	$-6.47M
Income after Taxes	$-6.47M
Income from Continuous Operations	$-6.47M
Consolidated Net Income/Loss	$-6.47M
Normalized Income after Taxes	$-6.47M
EBIT	$-6.47M
EBITDA	$-5.78M
Weighted-Average Shares Outstanding (Basic)	41.72M
Weighted-Average Shares Outstanding (Diluted)	41.72M
Earnings per Share (EPS) (Basic)	$-0.13
Earnings per Share (EPS) (Diluted)	$-0.13
Balance Sheet Financials
Current Assets	$14.61M
Property, Plant, and Equipment	$0.70M
Long-Term Assets	$1.85M
Total Assets	$16.46M
Current Liabilities	$3.38M
Long-Term Debt	$0.73M
Long-Term Liabilities	$0.78M
Total Liabilities	$4.16M
Common Equity	$12.30M
Tangible Shareholders Equity	$12.30M
Shareholders Equity	$12.30M
Common Shares Outstanding	41.82M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-4.38M
Cash Flow from Investing Activities	$-0.03M
Cash Flow from Financial Activities	$-0.73M
Beginning Cash	$15.13M
End Cash	$9.98M
Increase/Decrease in Cash	$-5.15M
Stock-Based Compensation	--
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.32
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.06
Debt to Equity Ratio	0.13
Gross Margin	79.08%
Operating Margin	-170.77%
EBIT Margin	-170.77%
EBITDA Margin	-152.48%
Pre-Tax Profit Margin	-170.77%
Profit Margin	-170.77%
Free Cash Flow	$-4.40M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.23
Inventory Turnover	0.64
Receiveable Turnover	1.12
Days Sales in Receivables	326.82
Return on Equity	-52.58%
Return on Tangible Equity	-52.58%
Return on Assets	-39.30%
Return on Investments	-49.62%
Book Value Per Share	$0.29
Free Cash Flow per Share	$-0.11
Operating Cash Flow per Share	$-0.10

Data from Zacks Investment Research, Inc.